Loading…

US Tobacco 21 Policies and Potential Mortality Reductions by State

Research shows that Tobacco 21 (T21) policies with a minimum legal access age for tobacco products of 21 years reduce smoking, yet their impact varies across US states due to differences in smoking behaviors, mortality rates, and policy coverage. To quantify potential reductions in smoking-attributa...

Full description

Saved in:
Bibliographic Details
Published in:JAMA health forum 2024-12, Vol.5 (12), p.e244445
Main Authors: Tam, Jamie, Crippen, Alyssa, Friedman, Abigail, Jeon, Jihyoun, Colston, David C, Fleischer, Nancy L, Vander Woude, Catherine A, Boelter, Megan A, Holford, Theodore R, Levy, David T, Meza, Rafael
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 12
container_start_page e244445
container_title JAMA health forum
container_volume 5
creator Tam, Jamie
Crippen, Alyssa
Friedman, Abigail
Jeon, Jihyoun
Colston, David C
Fleischer, Nancy L
Vander Woude, Catherine A
Boelter, Megan A
Holford, Theodore R
Levy, David T
Meza, Rafael
description Research shows that Tobacco 21 (T21) policies with a minimum legal access age for tobacco products of 21 years reduce smoking, yet their impact varies across US states due to differences in smoking behaviors, mortality rates, and policy coverage. To quantify potential reductions in smoking-attributable mortality associated with Tobacco 21 policies for each of the 50 states and Washington, DC. The Cancer Intervention Surveillance and Modeling Network (CISNET) Tobacco Control Policy Model of smoking was used with detailed state-specific data on smoking initiation, smoking cessation and mortality rates as they vary by age, gender, and birth cohort for 50 US states and the District of Columbia. This was integrated with comprehensive data on T21 policy coverage at the local and state levels from 2005 to 2024, and then T21 policy effects from quasi-experimental studies were applied to simulate each state's experience of T21 policies, quantifying potential mortality reductions from 2005 to 2100. Cigarette smoking. Estimated smoking-attributable deaths averted and life-years gained compared with a baseline scenario. Early statewide T21 adoption in California, combined with its large population, was associated with more than 27 000 premature deaths averted through 2100, whereas statewide implementation in Kentucky was associated with 15 000 averted premature deaths. In Massachusetts, T21 policies were associated with 8000 averted premature deaths, largely attributed to municipal T21 policies covering most residents. Wisconsin-lacking state or local policies-requires enforcement of federal T21 to prevent up to 10 000 premature deaths. Across the country, comprehensive enforcement of federal, state, and local T21 laws were associated with up to 526 000 premature deaths averted and 13.3 million life-years gained by 2100. Enforcement of only state and local policies was associated with 442 000 premature deaths averted. This study found that early adoption and implementation of T21 policies maximizes potential premature mortality reductions. However, the strength of T21 policies and enforcement varies widely across states. Enforcement of the federal T21 law is critical in the 8 states without state-level T21 cigarette policies of their own.
doi_str_mv 10.1001/jamahealthforum.2024.4445
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3147486835</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3147486835</sourcerecordid><originalsourceid>FETCH-LOGICAL-p565-e57ca87f7439fd730a98987c487f529c2c2ad649d9292da277f370e56d7001083</originalsourceid><addsrcrecordid>eNpNj8tKAzEYhYMottS-gsSdm6m5TpKlFm9QUWxdD3-TDJ2SmdRJZtG3d8AKrs6FjwMHoRtKFpQQereHFnYeQt7VsR_aBSNMLIQQ8gxNWalNQaguz__5CZqntCeEMElpqfglmnCjiCRCTtHD1xpv4hasjZhR_BFDYxufMHRuDNl3uYGA32KfITT5iD-9G2xuYpfw9ojXGbK_Qhc1hOTnJ52hzdPjZvlSrN6fX5f3q-IgS1l4qSxoVSvBTe0UJ2C00cqKsZPMWGYZuFIYZ5hhDphSNVfEy9Kp8TXRfIZuf2cPffwefMpV2yTrQ4DOxyFVnAoldKm5HNHrEzpsW--qQ9-00B-rv9v8B0pYXMk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3147486835</pqid></control><display><type>article</type><title>US Tobacco 21 Policies and Potential Mortality Reductions by State</title><source>Publicly Available Content Database</source><creator>Tam, Jamie ; Crippen, Alyssa ; Friedman, Abigail ; Jeon, Jihyoun ; Colston, David C ; Fleischer, Nancy L ; Vander Woude, Catherine A ; Boelter, Megan A ; Holford, Theodore R ; Levy, David T ; Meza, Rafael</creator><creatorcontrib>Tam, Jamie ; Crippen, Alyssa ; Friedman, Abigail ; Jeon, Jihyoun ; Colston, David C ; Fleischer, Nancy L ; Vander Woude, Catherine A ; Boelter, Megan A ; Holford, Theodore R ; Levy, David T ; Meza, Rafael</creatorcontrib><description>Research shows that Tobacco 21 (T21) policies with a minimum legal access age for tobacco products of 21 years reduce smoking, yet their impact varies across US states due to differences in smoking behaviors, mortality rates, and policy coverage. To quantify potential reductions in smoking-attributable mortality associated with Tobacco 21 policies for each of the 50 states and Washington, DC. The Cancer Intervention Surveillance and Modeling Network (CISNET) Tobacco Control Policy Model of smoking was used with detailed state-specific data on smoking initiation, smoking cessation and mortality rates as they vary by age, gender, and birth cohort for 50 US states and the District of Columbia. This was integrated with comprehensive data on T21 policy coverage at the local and state levels from 2005 to 2024, and then T21 policy effects from quasi-experimental studies were applied to simulate each state's experience of T21 policies, quantifying potential mortality reductions from 2005 to 2100. Cigarette smoking. Estimated smoking-attributable deaths averted and life-years gained compared with a baseline scenario. Early statewide T21 adoption in California, combined with its large population, was associated with more than 27 000 premature deaths averted through 2100, whereas statewide implementation in Kentucky was associated with 15 000 averted premature deaths. In Massachusetts, T21 policies were associated with 8000 averted premature deaths, largely attributed to municipal T21 policies covering most residents. Wisconsin-lacking state or local policies-requires enforcement of federal T21 to prevent up to 10 000 premature deaths. Across the country, comprehensive enforcement of federal, state, and local T21 laws were associated with up to 526 000 premature deaths averted and 13.3 million life-years gained by 2100. Enforcement of only state and local policies was associated with 442 000 premature deaths averted. This study found that early adoption and implementation of T21 policies maximizes potential premature mortality reductions. However, the strength of T21 policies and enforcement varies widely across states. Enforcement of the federal T21 law is critical in the 8 states without state-level T21 cigarette policies of their own.</description><identifier>ISSN: 2689-0186</identifier><identifier>EISSN: 2689-0186</identifier><identifier>DOI: 10.1001/jamahealthforum.2024.4445</identifier><identifier>PMID: 39705045</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Aged ; Female ; Health Policy - legislation &amp; jurisprudence ; Humans ; Male ; Middle Aged ; Smoking - adverse effects ; Smoking - epidemiology ; Smoking - legislation &amp; jurisprudence ; Smoking - mortality ; Smoking Cessation - legislation &amp; jurisprudence ; Smoking Prevention - legislation &amp; jurisprudence ; Tobacco Products - legislation &amp; jurisprudence ; United States - epidemiology</subject><ispartof>JAMA health forum, 2024-12, Vol.5 (12), p.e244445</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,37013</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39705045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tam, Jamie</creatorcontrib><creatorcontrib>Crippen, Alyssa</creatorcontrib><creatorcontrib>Friedman, Abigail</creatorcontrib><creatorcontrib>Jeon, Jihyoun</creatorcontrib><creatorcontrib>Colston, David C</creatorcontrib><creatorcontrib>Fleischer, Nancy L</creatorcontrib><creatorcontrib>Vander Woude, Catherine A</creatorcontrib><creatorcontrib>Boelter, Megan A</creatorcontrib><creatorcontrib>Holford, Theodore R</creatorcontrib><creatorcontrib>Levy, David T</creatorcontrib><creatorcontrib>Meza, Rafael</creatorcontrib><title>US Tobacco 21 Policies and Potential Mortality Reductions by State</title><title>JAMA health forum</title><addtitle>JAMA Health Forum</addtitle><description>Research shows that Tobacco 21 (T21) policies with a minimum legal access age for tobacco products of 21 years reduce smoking, yet their impact varies across US states due to differences in smoking behaviors, mortality rates, and policy coverage. To quantify potential reductions in smoking-attributable mortality associated with Tobacco 21 policies for each of the 50 states and Washington, DC. The Cancer Intervention Surveillance and Modeling Network (CISNET) Tobacco Control Policy Model of smoking was used with detailed state-specific data on smoking initiation, smoking cessation and mortality rates as they vary by age, gender, and birth cohort for 50 US states and the District of Columbia. This was integrated with comprehensive data on T21 policy coverage at the local and state levels from 2005 to 2024, and then T21 policy effects from quasi-experimental studies were applied to simulate each state's experience of T21 policies, quantifying potential mortality reductions from 2005 to 2100. Cigarette smoking. Estimated smoking-attributable deaths averted and life-years gained compared with a baseline scenario. Early statewide T21 adoption in California, combined with its large population, was associated with more than 27 000 premature deaths averted through 2100, whereas statewide implementation in Kentucky was associated with 15 000 averted premature deaths. In Massachusetts, T21 policies were associated with 8000 averted premature deaths, largely attributed to municipal T21 policies covering most residents. Wisconsin-lacking state or local policies-requires enforcement of federal T21 to prevent up to 10 000 premature deaths. Across the country, comprehensive enforcement of federal, state, and local T21 laws were associated with up to 526 000 premature deaths averted and 13.3 million life-years gained by 2100. Enforcement of only state and local policies was associated with 442 000 premature deaths averted. This study found that early adoption and implementation of T21 policies maximizes potential premature mortality reductions. However, the strength of T21 policies and enforcement varies widely across states. Enforcement of the federal T21 law is critical in the 8 states without state-level T21 cigarette policies of their own.</description><subject>Adult</subject><subject>Aged</subject><subject>Female</subject><subject>Health Policy - legislation &amp; jurisprudence</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Smoking - adverse effects</subject><subject>Smoking - epidemiology</subject><subject>Smoking - legislation &amp; jurisprudence</subject><subject>Smoking - mortality</subject><subject>Smoking Cessation - legislation &amp; jurisprudence</subject><subject>Smoking Prevention - legislation &amp; jurisprudence</subject><subject>Tobacco Products - legislation &amp; jurisprudence</subject><subject>United States - epidemiology</subject><issn>2689-0186</issn><issn>2689-0186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNj8tKAzEYhYMottS-gsSdm6m5TpKlFm9QUWxdD3-TDJ2SmdRJZtG3d8AKrs6FjwMHoRtKFpQQereHFnYeQt7VsR_aBSNMLIQQ8gxNWalNQaguz__5CZqntCeEMElpqfglmnCjiCRCTtHD1xpv4hasjZhR_BFDYxufMHRuDNl3uYGA32KfITT5iD-9G2xuYpfw9ojXGbK_Qhc1hOTnJ52hzdPjZvlSrN6fX5f3q-IgS1l4qSxoVSvBTe0UJ2C00cqKsZPMWGYZuFIYZ5hhDphSNVfEy9Kp8TXRfIZuf2cPffwefMpV2yTrQ4DOxyFVnAoldKm5HNHrEzpsW--qQ9-00B-rv9v8B0pYXMk</recordid><startdate>20241206</startdate><enddate>20241206</enddate><creator>Tam, Jamie</creator><creator>Crippen, Alyssa</creator><creator>Friedman, Abigail</creator><creator>Jeon, Jihyoun</creator><creator>Colston, David C</creator><creator>Fleischer, Nancy L</creator><creator>Vander Woude, Catherine A</creator><creator>Boelter, Megan A</creator><creator>Holford, Theodore R</creator><creator>Levy, David T</creator><creator>Meza, Rafael</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20241206</creationdate><title>US Tobacco 21 Policies and Potential Mortality Reductions by State</title><author>Tam, Jamie ; Crippen, Alyssa ; Friedman, Abigail ; Jeon, Jihyoun ; Colston, David C ; Fleischer, Nancy L ; Vander Woude, Catherine A ; Boelter, Megan A ; Holford, Theodore R ; Levy, David T ; Meza, Rafael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p565-e57ca87f7439fd730a98987c487f529c2c2ad649d9292da277f370e56d7001083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Female</topic><topic>Health Policy - legislation &amp; jurisprudence</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Smoking - adverse effects</topic><topic>Smoking - epidemiology</topic><topic>Smoking - legislation &amp; jurisprudence</topic><topic>Smoking - mortality</topic><topic>Smoking Cessation - legislation &amp; jurisprudence</topic><topic>Smoking Prevention - legislation &amp; jurisprudence</topic><topic>Tobacco Products - legislation &amp; jurisprudence</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tam, Jamie</creatorcontrib><creatorcontrib>Crippen, Alyssa</creatorcontrib><creatorcontrib>Friedman, Abigail</creatorcontrib><creatorcontrib>Jeon, Jihyoun</creatorcontrib><creatorcontrib>Colston, David C</creatorcontrib><creatorcontrib>Fleischer, Nancy L</creatorcontrib><creatorcontrib>Vander Woude, Catherine A</creatorcontrib><creatorcontrib>Boelter, Megan A</creatorcontrib><creatorcontrib>Holford, Theodore R</creatorcontrib><creatorcontrib>Levy, David T</creatorcontrib><creatorcontrib>Meza, Rafael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA health forum</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tam, Jamie</au><au>Crippen, Alyssa</au><au>Friedman, Abigail</au><au>Jeon, Jihyoun</au><au>Colston, David C</au><au>Fleischer, Nancy L</au><au>Vander Woude, Catherine A</au><au>Boelter, Megan A</au><au>Holford, Theodore R</au><au>Levy, David T</au><au>Meza, Rafael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>US Tobacco 21 Policies and Potential Mortality Reductions by State</atitle><jtitle>JAMA health forum</jtitle><addtitle>JAMA Health Forum</addtitle><date>2024-12-06</date><risdate>2024</risdate><volume>5</volume><issue>12</issue><spage>e244445</spage><pages>e244445-</pages><issn>2689-0186</issn><eissn>2689-0186</eissn><abstract>Research shows that Tobacco 21 (T21) policies with a minimum legal access age for tobacco products of 21 years reduce smoking, yet their impact varies across US states due to differences in smoking behaviors, mortality rates, and policy coverage. To quantify potential reductions in smoking-attributable mortality associated with Tobacco 21 policies for each of the 50 states and Washington, DC. The Cancer Intervention Surveillance and Modeling Network (CISNET) Tobacco Control Policy Model of smoking was used with detailed state-specific data on smoking initiation, smoking cessation and mortality rates as they vary by age, gender, and birth cohort for 50 US states and the District of Columbia. This was integrated with comprehensive data on T21 policy coverage at the local and state levels from 2005 to 2024, and then T21 policy effects from quasi-experimental studies were applied to simulate each state's experience of T21 policies, quantifying potential mortality reductions from 2005 to 2100. Cigarette smoking. Estimated smoking-attributable deaths averted and life-years gained compared with a baseline scenario. Early statewide T21 adoption in California, combined with its large population, was associated with more than 27 000 premature deaths averted through 2100, whereas statewide implementation in Kentucky was associated with 15 000 averted premature deaths. In Massachusetts, T21 policies were associated with 8000 averted premature deaths, largely attributed to municipal T21 policies covering most residents. Wisconsin-lacking state or local policies-requires enforcement of federal T21 to prevent up to 10 000 premature deaths. Across the country, comprehensive enforcement of federal, state, and local T21 laws were associated with up to 526 000 premature deaths averted and 13.3 million life-years gained by 2100. Enforcement of only state and local policies was associated with 442 000 premature deaths averted. This study found that early adoption and implementation of T21 policies maximizes potential premature mortality reductions. However, the strength of T21 policies and enforcement varies widely across states. Enforcement of the federal T21 law is critical in the 8 states without state-level T21 cigarette policies of their own.</abstract><cop>United States</cop><pmid>39705045</pmid><doi>10.1001/jamahealthforum.2024.4445</doi></addata></record>
fulltext fulltext
identifier ISSN: 2689-0186
ispartof JAMA health forum, 2024-12, Vol.5 (12), p.e244445
issn 2689-0186
2689-0186
language eng
recordid cdi_proquest_miscellaneous_3147486835
source Publicly Available Content Database
subjects Adult
Aged
Female
Health Policy - legislation & jurisprudence
Humans
Male
Middle Aged
Smoking - adverse effects
Smoking - epidemiology
Smoking - legislation & jurisprudence
Smoking - mortality
Smoking Cessation - legislation & jurisprudence
Smoking Prevention - legislation & jurisprudence
Tobacco Products - legislation & jurisprudence
United States - epidemiology
title US Tobacco 21 Policies and Potential Mortality Reductions by State
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A24%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=US%20Tobacco%2021%20Policies%20and%20Potential%20Mortality%20Reductions%20by%20State&rft.jtitle=JAMA%20health%20forum&rft.au=Tam,%20Jamie&rft.date=2024-12-06&rft.volume=5&rft.issue=12&rft.spage=e244445&rft.pages=e244445-&rft.issn=2689-0186&rft.eissn=2689-0186&rft_id=info:doi/10.1001/jamahealthforum.2024.4445&rft_dat=%3Cproquest_pubme%3E3147486835%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p565-e57ca87f7439fd730a98987c487f529c2c2ad649d9292da277f370e56d7001083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3147486835&rft_id=info:pmid/39705045&rfr_iscdi=true